Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C Infusion for Severe COVID-19 Pneumonia
NCT04264533Phase 2Terminated
- Start
- Feb 2020
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ascorbic acid in COVID-19 pneumonia. Started Feb 2020; status: terminated.
02
Drugs
ascorbic acid
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04264533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04264533.